nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—ABCB1—peripheral nervous system neoplasm	0.308	1	CbGaD
Sparfloxacin—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.0964	0.187	CbGbCtD
Sparfloxacin—TOP2A—Etoposide—peripheral nervous system neoplasm	0.0751	0.145	CbGbCtD
Sparfloxacin—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.0702	0.136	CbGbCtD
Sparfloxacin—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.0512	0.0991	CbGbCtD
Sparfloxacin—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0336	0.0651	CbGbCtD
Sparfloxacin—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0314	0.0607	CbGbCtD
Sparfloxacin—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0308	0.0596	CbGbCtD
Sparfloxacin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0257	0.0497	CbGbCtD
Sparfloxacin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0257	0.0497	CbGbCtD
Sparfloxacin—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.021	0.0407	CbGbCtD
Sparfloxacin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0178	0.0344	CbGbCtD
Sparfloxacin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.011	0.0212	CbGbCtD
Sparfloxacin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0102	0.0198	CbGbCtD
Sparfloxacin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.01	0.0194	CbGbCtD
Sparfloxacin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00685	0.0133	CbGbCtD
Sparfloxacin—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000882	0.244	CbGdCrCtD
Sparfloxacin—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	0.000524	0.145	CbGdCrCtD
Sparfloxacin—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.00033	0.0913	CbGdCrCtD
Sparfloxacin—TOP2A—Podofilox—Etoposide—peripheral nervous system neoplasm	0.00033	0.0913	CbGdCrCtD
Sparfloxacin—TOP2A—Teniposide—Etoposide—peripheral nervous system neoplasm	0.00033	0.0913	CbGdCrCtD
Sparfloxacin—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000227	0.0628	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.000172	0.0476	CbGdCrCtD
Sparfloxacin—TOP2A—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.000172	0.0476	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.000172	0.0476	CbGdCrCtD
Sparfloxacin—TOP2A—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.044	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.044	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.044	CbGdCrCtD
Sparfloxacin—Levofloxacin—ABCB1—peripheral nervous system neoplasm	0.000124	0.509	CrCbGaD
Sparfloxacin—Ciprofloxacin—ABCB1—peripheral nervous system neoplasm	0.00012	0.491	CrCbGaD
Sparfloxacin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	8.53e-05	0.000499	CcSEcCtD
Sparfloxacin—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	8.53e-05	0.000499	CcSEcCtD
Sparfloxacin—Anorexia—Cisplatin—peripheral nervous system neoplasm	8.52e-05	0.000498	CcSEcCtD
Sparfloxacin—Affect lability—Doxorubicin—peripheral nervous system neoplasm	8.51e-05	0.000497	CcSEcCtD
Sparfloxacin—Migraine—Doxorubicin—peripheral nervous system neoplasm	8.51e-05	0.000497	CcSEcCtD
Sparfloxacin—Discomfort—Etoposide—peripheral nervous system neoplasm	8.44e-05	0.000494	CcSEcCtD
Sparfloxacin—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	8.41e-05	0.000492	CcSEcCtD
Sparfloxacin—Face oedema—Doxorubicin—peripheral nervous system neoplasm	8.35e-05	0.000488	CcSEcCtD
Sparfloxacin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	8.34e-05	0.000487	CcSEcCtD
Sparfloxacin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	8.34e-05	0.000487	CcSEcCtD
Sparfloxacin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	8.3e-05	0.000485	CcSEcCtD
Sparfloxacin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	8.3e-05	0.000485	CcSEcCtD
Sparfloxacin—Nausea—Topotecan—peripheral nervous system neoplasm	8.29e-05	0.000485	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	8.27e-05	0.000483	CcSEcCtD
Sparfloxacin—Confusional state—Etoposide—peripheral nervous system neoplasm	8.26e-05	0.000483	CcSEcCtD
Sparfloxacin—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000482	CcSEcCtD
Sparfloxacin—Nausea—Tretinoin—peripheral nervous system neoplasm	8.23e-05	0.000481	CcSEcCtD
Sparfloxacin—Nausea—Isotretinoin—peripheral nervous system neoplasm	8.23e-05	0.000481	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	8.19e-05	0.000479	CcSEcCtD
Sparfloxacin—Mood swings—Doxorubicin—peripheral nervous system neoplasm	8.19e-05	0.000479	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	8.15e-05	0.000476	CcSEcCtD
Sparfloxacin—Ataxia—Doxorubicin—peripheral nervous system neoplasm	8.13e-05	0.000475	CcSEcCtD
Sparfloxacin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	8.12e-05	0.000475	CcSEcCtD
Sparfloxacin—Nausea—Melphalan—peripheral nervous system neoplasm	8.12e-05	0.000475	CcSEcCtD
Sparfloxacin—Asthma—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000472	CcSEcCtD
Sparfloxacin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	8.03e-05	0.000469	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	8.02e-05	0.000469	CcSEcCtD
Sparfloxacin—Tachycardia—Etoposide—peripheral nervous system neoplasm	7.99e-05	0.000467	CcSEcCtD
Sparfloxacin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	7.99e-05	0.000467	CcSEcCtD
Sparfloxacin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	7.99e-05	0.000467	CcSEcCtD
Sparfloxacin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	7.97e-05	0.000466	CcSEcCtD
Sparfloxacin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.000463	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	7.92e-05	0.000463	CcSEcCtD
Sparfloxacin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	7.92e-05	0.000463	CcSEcCtD
Sparfloxacin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000462	CcSEcCtD
Sparfloxacin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000462	CcSEcCtD
Sparfloxacin—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	7.87e-05	0.00046	CcSEcCtD
Sparfloxacin—Anorexia—Etoposide—peripheral nervous system neoplasm	7.81e-05	0.000456	CcSEcCtD
Sparfloxacin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	7.78e-05	0.000455	CcSEcCtD
Sparfloxacin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	7.77e-05	0.000454	CcSEcCtD
Sparfloxacin—Bronchitis—Epirubicin—peripheral nervous system neoplasm	7.77e-05	0.000454	CcSEcCtD
Sparfloxacin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	7.74e-05	0.000453	CcSEcCtD
Sparfloxacin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	7.73e-05	0.000452	CcSEcCtD
Sparfloxacin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	7.67e-05	0.000448	CcSEcCtD
Sparfloxacin—Pain—Cisplatin—peripheral nervous system neoplasm	7.65e-05	0.000447	CcSEcCtD
Sparfloxacin—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.000446	CcSEcCtD
Sparfloxacin—Dysuria—Epirubicin—peripheral nervous system neoplasm	7.55e-05	0.000441	CcSEcCtD
Sparfloxacin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	7.53e-05	0.00044	CcSEcCtD
Sparfloxacin—Asthma—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000437	CcSEcCtD
Sparfloxacin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	7.45e-05	0.000436	CcSEcCtD
Sparfloxacin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	7.42e-05	0.000434	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	7.37e-05	0.000431	CcSEcCtD
Sparfloxacin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	7.37e-05	0.000431	CcSEcCtD
Sparfloxacin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	7.36e-05	0.00043	CcSEcCtD
Sparfloxacin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	7.33e-05	0.000428	CcSEcCtD
Sparfloxacin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	7.3e-05	0.000427	CcSEcCtD
Sparfloxacin—Somnolence—Etoposide—peripheral nervous system neoplasm	7.28e-05	0.000426	CcSEcCtD
Sparfloxacin—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	7.28e-05	0.000425	CcSEcCtD
Sparfloxacin—Asthenia—Vincristine—peripheral nervous system neoplasm	7.26e-05	0.000424	CcSEcCtD
Sparfloxacin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	7.24e-05	0.000423	CcSEcCtD
Sparfloxacin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	7.2e-05	0.000421	CcSEcCtD
Sparfloxacin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	7.19e-05	0.00042	CcSEcCtD
Sparfloxacin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	7.18e-05	0.00042	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	7.14e-05	0.000417	CcSEcCtD
Sparfloxacin—Rash—Dactinomycin—peripheral nervous system neoplasm	7.14e-05	0.000417	CcSEcCtD
Sparfloxacin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.12e-05	0.000416	CcSEcCtD
Sparfloxacin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	7.1e-05	0.000415	CcSEcCtD
Sparfloxacin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	7.07e-05	0.000413	CcSEcCtD
Sparfloxacin—Jaundice—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.00041	CcSEcCtD
Sparfloxacin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.00041	CcSEcCtD
Sparfloxacin—Pain—Etoposide—peripheral nervous system neoplasm	7.01e-05	0.000409	CcSEcCtD
Sparfloxacin—Constipation—Etoposide—peripheral nervous system neoplasm	7.01e-05	0.000409	CcSEcCtD
Sparfloxacin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000409	CcSEcCtD
Sparfloxacin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000409	CcSEcCtD
Sparfloxacin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000408	CcSEcCtD
Sparfloxacin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	6.94e-05	0.000406	CcSEcCtD
Sparfloxacin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	6.92e-05	0.000404	CcSEcCtD
Sparfloxacin—Sweating—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.000403	CcSEcCtD
Sparfloxacin—Haematuria—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000401	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	0.000399	CcSEcCtD
Sparfloxacin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	6.79e-05	0.000397	CcSEcCtD
Sparfloxacin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000395	CcSEcCtD
Sparfloxacin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	6.75e-05	0.000395	CcSEcCtD
Sparfloxacin—Nausea—Dactinomycin—peripheral nervous system neoplasm	6.72e-05	0.000393	CcSEcCtD
Sparfloxacin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	6.72e-05	0.000393	CcSEcCtD
Sparfloxacin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	6.7e-05	0.000392	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	6.7e-05	0.000392	CcSEcCtD
Sparfloxacin—Dizziness—Vincristine—peripheral nervous system neoplasm	6.69e-05	0.000391	CcSEcCtD
Sparfloxacin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	6.67e-05	0.00039	CcSEcCtD
Sparfloxacin—Rash—Alitretinoin—peripheral nervous system neoplasm	6.62e-05	0.000387	CcSEcCtD
Sparfloxacin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	6.61e-05	0.000386	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	6.6e-05	0.000386	CcSEcCtD
Sparfloxacin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	6.59e-05	0.000385	CcSEcCtD
Sparfloxacin—Headache—Alitretinoin—peripheral nervous system neoplasm	6.57e-05	0.000384	CcSEcCtD
Sparfloxacin—Urticaria—Etoposide—peripheral nervous system neoplasm	6.51e-05	0.00038	CcSEcCtD
Sparfloxacin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	6.5e-05	0.00038	CcSEcCtD
Sparfloxacin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	6.49e-05	0.00038	CcSEcCtD
Sparfloxacin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	6.49e-05	0.00038	CcSEcCtD
Sparfloxacin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.000379	CcSEcCtD
Sparfloxacin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	6.48e-05	0.000379	CcSEcCtD
Sparfloxacin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	6.48e-05	0.000379	CcSEcCtD
Sparfloxacin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000379	CcSEcCtD
Sparfloxacin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000379	CcSEcCtD
Sparfloxacin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.000378	CcSEcCtD
Sparfloxacin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.000378	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.000376	CcSEcCtD
Sparfloxacin—Vomiting—Vincristine—peripheral nervous system neoplasm	6.43e-05	0.000376	CcSEcCtD
Sparfloxacin—Asthenia—Cisplatin—peripheral nervous system neoplasm	6.42e-05	0.000375	CcSEcCtD
Sparfloxacin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000375	CcSEcCtD
Sparfloxacin—Sweating—Doxorubicin—peripheral nervous system neoplasm	6.39e-05	0.000373	CcSEcCtD
Sparfloxacin—Rash—Vincristine—peripheral nervous system neoplasm	6.38e-05	0.000373	CcSEcCtD
Sparfloxacin—Dermatitis—Vincristine—peripheral nervous system neoplasm	6.37e-05	0.000372	CcSEcCtD
Sparfloxacin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000372	CcSEcCtD
Sparfloxacin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000371	CcSEcCtD
Sparfloxacin—Headache—Vincristine—peripheral nervous system neoplasm	6.33e-05	0.00037	CcSEcCtD
Sparfloxacin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	6.28e-05	0.000367	CcSEcCtD
Sparfloxacin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000365	CcSEcCtD
Sparfloxacin—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.23e-05	0.000364	CcSEcCtD
Sparfloxacin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.000363	CcSEcCtD
Sparfloxacin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.12e-05	0.000358	CcSEcCtD
Sparfloxacin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	6.11e-05	0.000357	CcSEcCtD
Sparfloxacin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	6.04e-05	0.000353	CcSEcCtD
Sparfloxacin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	6.03e-05	0.000352	CcSEcCtD
Sparfloxacin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	6.01e-05	0.000351	CcSEcCtD
Sparfloxacin—Nausea—Vincristine—peripheral nervous system neoplasm	6.01e-05	0.000351	CcSEcCtD
Sparfloxacin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	6e-05	0.00035	CcSEcCtD
Sparfloxacin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.00035	CcSEcCtD
Sparfloxacin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.00035	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000348	CcSEcCtD
Sparfloxacin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000347	CcSEcCtD
Sparfloxacin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.000344	CcSEcCtD
Sparfloxacin—Asthenia—Etoposide—peripheral nervous system neoplasm	5.88e-05	0.000344	CcSEcCtD
Sparfloxacin—Chills—Epirubicin—peripheral nervous system neoplasm	5.8e-05	0.000339	CcSEcCtD
Sparfloxacin—Pruritus—Etoposide—peripheral nervous system neoplasm	5.8e-05	0.000339	CcSEcCtD
Sparfloxacin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.000338	CcSEcCtD
Sparfloxacin—Alopecia—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000334	CcSEcCtD
Sparfloxacin—Vomiting—Cisplatin—peripheral nervous system neoplasm	5.69e-05	0.000332	CcSEcCtD
Sparfloxacin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	5.65e-05	0.000331	CcSEcCtD
Sparfloxacin—Rash—Cisplatin—peripheral nervous system neoplasm	5.64e-05	0.00033	CcSEcCtD
Sparfloxacin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	5.63e-05	0.000329	CcSEcCtD
Sparfloxacin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	5.6e-05	0.000328	CcSEcCtD
Sparfloxacin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	5.58e-05	0.000326	CcSEcCtD
Sparfloxacin—Flatulence—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000324	CcSEcCtD
Sparfloxacin—Tension—Epirubicin—peripheral nervous system neoplasm	5.52e-05	0.000323	CcSEcCtD
Sparfloxacin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000322	CcSEcCtD
Sparfloxacin—Nervousness—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000319	CcSEcCtD
Sparfloxacin—Back pain—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.000318	CcSEcCtD
Sparfloxacin—Dizziness—Etoposide—peripheral nervous system neoplasm	5.42e-05	0.000317	CcSEcCtD
Sparfloxacin—Chills—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000314	CcSEcCtD
Sparfloxacin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.000312	CcSEcCtD
Sparfloxacin—Nausea—Cisplatin—peripheral nervous system neoplasm	5.31e-05	0.00031	CcSEcCtD
Sparfloxacin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000309	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	5.22e-05	0.000305	CcSEcCtD
Sparfloxacin—Vomiting—Etoposide—peripheral nervous system neoplasm	5.21e-05	0.000304	CcSEcCtD
Sparfloxacin—Agitation—Epirubicin—peripheral nervous system neoplasm	5.17e-05	0.000302	CcSEcCtD
Sparfloxacin—Rash—Etoposide—peripheral nervous system neoplasm	5.16e-05	0.000302	CcSEcCtD
Sparfloxacin—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.16e-05	0.000302	CcSEcCtD
Sparfloxacin—Headache—Etoposide—peripheral nervous system neoplasm	5.13e-05	0.0003	CcSEcCtD
Sparfloxacin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	5.13e-05	0.0003	CcSEcCtD
Sparfloxacin—Tension—Doxorubicin—peripheral nervous system neoplasm	5.11e-05	0.000299	CcSEcCtD
Sparfloxacin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	5.1e-05	0.000298	CcSEcCtD
Sparfloxacin—Malaise—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.000297	CcSEcCtD
Sparfloxacin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.000296	CcSEcCtD
Sparfloxacin—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.05e-05	0.000295	CcSEcCtD
Sparfloxacin—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.04e-05	0.000294	CcSEcCtD
Sparfloxacin—Palpitations—Epirubicin—peripheral nervous system neoplasm	4.97e-05	0.000291	CcSEcCtD
Sparfloxacin—Cough—Epirubicin—peripheral nervous system neoplasm	4.91e-05	0.000287	CcSEcCtD
Sparfloxacin—Convulsion—Epirubicin—peripheral nervous system neoplasm	4.87e-05	0.000285	CcSEcCtD
Sparfloxacin—Nausea—Etoposide—peripheral nervous system neoplasm	4.87e-05	0.000284	CcSEcCtD
Sparfloxacin—Hypertension—Epirubicin—peripheral nervous system neoplasm	4.86e-05	0.000284	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000282	CcSEcCtD
Sparfloxacin—Chest pain—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.00028	CcSEcCtD
Sparfloxacin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.00028	CcSEcCtD
Sparfloxacin—Myalgia—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.00028	CcSEcCtD
Sparfloxacin—Agitation—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.00028	CcSEcCtD
Sparfloxacin—Anxiety—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000279	CcSEcCtD
Sparfloxacin—Discomfort—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000277	CcSEcCtD
Sparfloxacin—Malaise—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000274	CcSEcCtD
Sparfloxacin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	4.68e-05	0.000274	CcSEcCtD
Sparfloxacin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	4.68e-05	0.000273	CcSEcCtD
Sparfloxacin—Confusional state—Epirubicin—peripheral nervous system neoplasm	4.63e-05	0.000271	CcSEcCtD
Sparfloxacin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	4.6e-05	0.000269	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	4.59e-05	0.000268	CcSEcCtD
Sparfloxacin—Cough—Doxorubicin—peripheral nervous system neoplasm	4.54e-05	0.000266	CcSEcCtD
Sparfloxacin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000264	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000263	CcSEcCtD
Sparfloxacin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	0.000263	CcSEcCtD
Sparfloxacin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000262	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.44e-05	0.000259	CcSEcCtD
Sparfloxacin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000259	CcSEcCtD
Sparfloxacin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000259	CcSEcCtD
Sparfloxacin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000259	CcSEcCtD
Sparfloxacin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.000258	CcSEcCtD
Sparfloxacin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000256	CcSEcCtD
Sparfloxacin—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.38e-05	0.000256	CcSEcCtD
Sparfloxacin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000253	CcSEcCtD
Sparfloxacin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	4.28e-05	0.00025	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.000248	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.18e-05	0.000245	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000243	CcSEcCtD
Sparfloxacin—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000243	CcSEcCtD
Sparfloxacin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000242	CcSEcCtD
Sparfloxacin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.12e-05	0.000241	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.00024	CcSEcCtD
Sparfloxacin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.000239	CcSEcCtD
Sparfloxacin—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.08e-05	0.000239	CcSEcCtD
Sparfloxacin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000237	CcSEcCtD
Sparfloxacin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.04e-05	0.000236	CcSEcCtD
Sparfloxacin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000233	CcSEcCtD
Sparfloxacin—Pain—Epirubicin—peripheral nervous system neoplasm	3.93e-05	0.00023	CcSEcCtD
Sparfloxacin—Constipation—Epirubicin—peripheral nervous system neoplasm	3.93e-05	0.00023	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.000226	CcSEcCtD
Sparfloxacin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000225	CcSEcCtD
Sparfloxacin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000223	CcSEcCtD
Sparfloxacin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.79e-05	0.000221	CcSEcCtD
Sparfloxacin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.78e-05	0.000221	CcSEcCtD
Sparfloxacin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000221	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3.75e-05	0.000219	CcSEcCtD
Sparfloxacin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.74e-05	0.000219	CcSEcCtD
Sparfloxacin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000216	CcSEcCtD
Sparfloxacin—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.65e-05	0.000213	CcSEcCtD
Sparfloxacin—Pain—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.000212	CcSEcCtD
Sparfloxacin—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.000212	CcSEcCtD
Sparfloxacin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.63e-05	0.000212	CcSEcCtD
Sparfloxacin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.63e-05	0.000212	CcSEcCtD
Sparfloxacin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.5e-05	0.000205	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.47e-05	0.000203	CcSEcCtD
Sparfloxacin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000198	CcSEcCtD
Sparfloxacin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000197	CcSEcCtD
Sparfloxacin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.36e-05	0.000196	CcSEcCtD
Sparfloxacin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.36e-05	0.000196	CcSEcCtD
Sparfloxacin—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000193	CcSEcCtD
Sparfloxacin—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.25e-05	0.00019	CcSEcCtD
Sparfloxacin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000184	CcSEcCtD
Sparfloxacin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000183	CcSEcCtD
Sparfloxacin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000178	CcSEcCtD
Sparfloxacin—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.04e-05	0.000177	CcSEcCtD
Sparfloxacin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.01e-05	0.000176	CcSEcCtD
Sparfloxacin—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.92e-05	0.000171	CcSEcCtD
Sparfloxacin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.00017	CcSEcCtD
Sparfloxacin—Rash—Epirubicin—peripheral nervous system neoplasm	2.9e-05	0.000169	CcSEcCtD
Sparfloxacin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.89e-05	0.000169	CcSEcCtD
Sparfloxacin—Headache—Epirubicin—peripheral nervous system neoplasm	2.88e-05	0.000168	CcSEcCtD
Sparfloxacin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.81e-05	0.000164	CcSEcCtD
Sparfloxacin—Nausea—Epirubicin—peripheral nervous system neoplasm	2.73e-05	0.000159	CcSEcCtD
Sparfloxacin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	0.000158	CcSEcCtD
Sparfloxacin—Rash—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000157	CcSEcCtD
Sparfloxacin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000156	CcSEcCtD
Sparfloxacin—Headache—Doxorubicin—peripheral nervous system neoplasm	2.66e-05	0.000156	CcSEcCtD
Sparfloxacin—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.52e-05	0.000148	CcSEcCtD
